IL6 and diabetes mellitus: Notably, the PI3K-Akt signaling pathway, a critical pathway in diabetes, was enriched with additional key targets, including IL6, HSP90AA1, FN1, MAPK1, AKT1, PIK3R1, and MAPK3.